Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-24

Clinical Trial Update: Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levetiracetam to magnesium sulfate for seizure prevention in severe preeclampsia/eclampsia is planned and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Nebraska Methodist Health System | Conditions: Severe Preeclampsia, Eclampsia Preeclampsia | Phase 3 | Status: NOT_YET_RECRUITING